EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Combined Therapy of Cyclosporine A, Mycophenolate, Losartan, and Finerenone in Drug-Resistant NOS-Focal Segmental Glomerulosclerosis

Kamel El-Reshaid, Shaikha Al-Bader, Ahmad Altaleb

Open Journal of Nephrology · 2026 · 16 (02) · 304-310

DOI: 10.4236/ojneph.2026.162027 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Open Journal of Nephrology, 2026. Verfasst von Kamel El-Reshaid und 2 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

El-Reshaid, K., Al-Bader, S., & Altaleb, A. (2026). Combined Therapy of Cyclosporine A, Mycophenolate, Losartan, and Finerenone in Drug-Resistant NOS-Focal Segmental Glomerulosclerosis. Open Journal of Nephrology, 16(02), 304-310. https://doi.org/10.4236/ojneph.2026.162027

Vancouver

El-Reshaid K, Al-Bader S, Altaleb A. Combined Therapy of Cyclosporine A, Mycophenolate, Losartan, and Finerenone in Drug-Resistant NOS-Focal Segmental Glomerulosclerosis. Open Journal of Nephrology. 2026;16(02):304-310. doi:10.4236/ojneph.2026.162027

BibTeX
@article{ElReshaid2026,
  author = {El-Reshaid, Kamel and Al-Bader, Shaikha and Altaleb, Ahmad},
  title = {Combined Therapy of Cyclosporine A, Mycophenolate, Losartan, and Finerenone in Drug-Resistant NOS-Focal Segmental Glomerulosclerosis},
  journal = {Open Journal of Nephrology},
  year = {2026},
  volume = {16},
  number = {02},
  pages = {304--310},
  doi = {10.4236/ojneph.2026.162027}
}
Kostenlos starten →